Difference between revisions of "QIBA Profile Conformance"

From QIBA Wiki
Jump to: navigation, search
(DWI MR: ADC of Lesions in Four Organs)
 
(49 intermediate revisions by 4 users not shown)
Line 8: Line 8:
 
As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:
 
As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:
  
::[[Image:Profile Conformance Image2.jpg|500px]]
 
 
::[[Image:Profile Conformance Image3.png|500px]]
 
::[[Image:Profile Conformance Image3.png|500px]]
  
 
== <font color=blue>Before starting conformance testing, please </font> [mailto:qiba@rsna.org Email QIBA] ==
 
== <font color=blue>Before starting conformance testing, please </font> [mailto:qiba@rsna.org Email QIBA] ==
  
== <font color=purple>'''QIBA or Designee Testing of Conformance'''</font> ==
+
== <font color=purple>'''Certification Service for Conformance'''</font> ==
  
 
===CT Small Lung Nodule Volumetry for Screening===
 
===CT Small Lung Nodule Volumetry for Screening===
Line 24: Line 23:
  
 
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
 
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
 +
 +
See '''[[Profile Conformance]]'''
  
 
===CT: Lung Tumor Volume (Advanced Disease)===
 
===CT: Lung Tumor Volume (Advanced Disease)===
'''Profile'''
+
:'''Profile'''
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
+
:* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
'''Checklist'''
+
:'''Checklist'''
* [[Media: QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Checklist_20191111.pdf | CT Conformance Checklist]] (can also refer to Appendix C in the Profile document - pg 42)
+
:* [[Media: QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Checklist_20191111.pdf | Conformance Checklist]] (contains Appendix C extracted from the Profile document - pg 42)
* Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
+
:* [[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | Assessment Procedures]] (contains Section 4 extracted from the Profile document - pg 30)
:*[[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | CT Conformance Testing Supplement, 2019-11-11]]  
+
:'''Report Template'''
'''Report Template'''
+
:*[[Media:QIBA_Conformance_Statement-Self-Attestation_CTvolAD_20191111-confirmed.pdf | Conformance Statement - Self-Attestation]]
:*[[Media:QIBA_Conformance_Statement-Self-Attestation_CTvolAD_20191111-confirmed.pdf | CT Conformance Self - Attestation Document, 2019-11-11]]
+
  
 
===FDG-PET: Solid Tumor SUV===
 
===FDG-PET: Solid Tumor SUV===
'''Profile'''
+
:'''Profile'''
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
+
:* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
'''Checklist'''
+
 
* [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]]
+
:'''Checklist for sites'''
'''Report Template'''
+
:* [[Media:2021-03-31.pdf | QIBA FDG-PET/CT Conformance Checklist 2021-03-31]]
* [[Media:QIBA_Conformance_Statement-Self-Attestation_FDG-PET_20191811_confirmed.pdf | QIBA FDG-PET/CT Conformance Self - Attestation Document, 2019-11-11]]
+
 
 +
 
 +
:'''Checklist for clinical trial'''
 +
 
 +
 
 +
:'''Reporting'''
 +
:*Please fill out your respective checklist and [mailto:qiba@rsna.org Email QIBA] for conformance assessment.
  
 
===DWI MR: ADC of Lesions in Four Organs===
 
===DWI MR: ADC of Lesions in Four Organs===
'''Profile'''
+
:'''Profile'''
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]]
+
 
'''Checklist'''
+
:*[[Media:QIBA_DWIProfile_Consensus_Dec2019_Final.pdf| MR Diffusion-Weighted Imaging (DWI) 2019-12-20]]
*[[Media:QIBA DWI Profile _Conformance Testing_Checklist_20191111.pdf | QIBA DWI-MRI Conformance Checklist, 2019-11-11]]
+
 
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 1_20191111.pdf | QIBA DWI Conformance Testing Supplement #1, 2019-11-11]]
+
:'''Checklist for sites'''
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]]
+
 
'''Report Template'''
+
:*[[Media:QIBA DWI Profile _Conformance Testing_Checklist_20191111.pdf | QIBA DWI-MRI Conformance Checklist, 2019-11-11]]
*[[Media:QIBA_Conformance_Statement-Self-Attestation_ADC_20191411_confirmed.pdf | QIBA DWI Conformance Self - Attestation Document, 2019-11-11]]
+
:**[[Media:QIBA_DWI_Profile__Conformance_Testing_Supplement_1_20210401a.pdf | QIBA DWI Conformance Testing Supplement #1, 2021-04-01]]
 +
:**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]]
 +
 
 +
:'''Checklist for software providers'''
 +
 
 +
:*[[Media:QIBA_DWI_Profile_SW_Provider_Conformance-Testing_Checklist_20210601.pdf | QIBA DWI-MRI Conformance Checklist, 2021-06-01]]
 +
:**[[Media:QIBA_DWI_Profile__Conformance_Testing_Supplement_1_20210401a.pdf | QIBA DWI Conformance Testing Supplement #1, 2021-04-01]]
 +
:**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]]
 +
 
 +
:'''Checklist for clinical trial'''
 +
 
 +
:**[[Media:QIBA_DWI_Profile__Conformance_Testing_Supplement_1_20210401a.pdf | QIBA DWI Conformance Testing Supplement #1, 2021-04-01]]
 +
:**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]]
 +
 
 +
 
 +
:'''Reporting'''
 +
:*Please fill out your respective checklist and [mailto:qiba@rsna.org Email QIBA] for conformance assessment.
 +
 
 +
==<font color=blue>'''[[List of Registered Conformant Users (Self-attestation)]]'''</font>==
 +
 
 +
==<font color=blue>'''[[List of Certified Conformant Users (QIBA Tested)]]'''</font>==

Latest revision as of 19:27, 8 September 2021

Self-attestation (Registered) or QIBA Tested (Certified) Opportunities

{This content will eventually be available on the RSNA.org website.}

QIBA Profiles that are at least at the Consensus Stage are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile.

As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:

Profile Conformance Image3.png

Before starting conformance testing, please Email QIBA

Certification Service for Conformance

CT Small Lung Nodule Volumetry for Screening


Self Attestation of Conformance

The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.

See Profile Conformance

CT: Lung Tumor Volume (Advanced Disease)

Profile
Checklist
Report Template

FDG-PET: Solid Tumor SUV

Profile
Checklist for sites


Checklist for clinical trial


Reporting
  • Please fill out your respective checklist and Email QIBA for conformance assessment.

DWI MR: ADC of Lesions in Four Organs

Profile
Checklist for sites
Checklist for software providers
Checklist for clinical trial


Reporting
  • Please fill out your respective checklist and Email QIBA for conformance assessment.

List of Registered Conformant Users (Self-attestation)

List of Certified Conformant Users (QIBA Tested)